The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity : A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
Latva-Rasku, Aino; Honka, Miikka-Juhani; Kullberg, Joel; Mononen, Nina; Lehtimäki, Terho; Saltevo, Juha; Kirjavainen, Anna K.; Saunavaara, Virva; Iozzo, Patricia; Johansson, Lars; Oscarsson, Jan; Hannukainen, Jarna C.; Nuutila, Pirjo (2019)
2019
Diabetes Care 42 5
931-937
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.